Article
C. difficile exploits a host metabolite produced during toxin-mediated disease.
Nature - 1 May 2021
Pruss Kali M, Sonnenburg Justin L
Abstract excerpt
Several enteric pathogens can gain specific metabolic advantages over other members of the microbiota by inducing host pathology and inflammation. The pathogen Clostridium difficile is responsible for a toxin-mediated colitis that causes 450,000 infections and 15,000 deaths in the United States each year1; however, the molecular mechanisms by which C. difficile benefits from this pathology remain unclear. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
